ArticleArthritis & rheumatology (Hoboken, N.J.)2016

Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.

Kichul Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.